comprehensive -WSS

comprehensive

author：focus 2025-10-02 23:38:09 - browse：975

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Biotech companies concerned about China biosecurity crackdown

WSS

Kenai launches with $82 million for Parkinson’s stem cell therapy

Flu vaccine offering decent levels of protection this winter, new data show

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Why getting cancer drugs just got harder for rural patients

FogPharma raises $145 million in rare Series E round

Sports medicine is finally prioritizing gender equality

entertainment

comprehensive

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Obesity now affects over 1 billion people worldwide, study finds

Jerome Adams on the need for new antivirals for Covid

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Trump demands the U.S. pay no more for drugs than other countries … again

Wildfire smoke exposes gaps in outdoor worker protections

Apple is now the first public company to be valued at $3 trillion

How one medical school became remarkably diverse

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

State Dept. review finds Biden bears some blame for Afghanistan failures

hotspot

House looks to weaken Medicare negotiation

Kenai launches with $82 million for Parkinson’s stem cell therapy

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

In Memoriam: Notable people who died in 2023

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

International team creates first chimeric human

knowledge

hotspot

leisure time

leisure time